Trials / Recruiting
RecruitingNCT07317206
Ayahuasca, Esketamine and PTSD
Effects of Single Dose of Ayahuasca or Esketamine on Posttraumatic Stress Disorder: a Randomized, Double-blinded Study
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ayahuasca | oral ayahuasca |
| DRUG | Esketamine | oral esketamine |
Timeline
- Start date
- 2025-12-20
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
- First posted
- 2026-01-05
- Last updated
- 2026-01-05
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT07317206. Inclusion in this directory is not an endorsement.